货币 / ALVO
ALVO: Alvotech
9.28
USD
0.43
(4.43%)
今日ALVO汇率已更改-4.43%。当日,交易品种以低点9.14和高点9.73进行交易。
关注Alvotech动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ALVO新闻
- Zacks Alvotech Gears Up to Report Q2 Earnings: Here's What to Expect
- Zacks Dr. Reddy's Q1 Earnings Beat Estimates, Generics Sales Boost Revenues
- Zacks Wall Street Analysts See a 91.05% Upside in Alvotech (ALVO): Can the Stock Really Move This High?
- Zacks Down 6.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Alvotech (ALVO)
- Seeking Alpha Alvotech: A Fast Expanding Biosimilar Concern (NASDAQ:ALVO)
- Benzinga Why Is Alvotech Stock Trading Higher On Wednesday? - Alvotech (NASDAQ:ALVO)
- Investing Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair ® (omalizumab)
- Investing Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair ® (omalizumab)
- Investing European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea ® (aflibercept)
- Investing European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea ® (aflibercept)
- Investing Alvotech completes private placement with 40 institutional investors
- Investing Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami
- Investing Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
- Benzinga Why Is Dr Reddy's Stock Trading Higher On Thursday? - Dr Reddy's Laboratories (NYSE:RDY), Alvotech (NASDAQ:ALVO)
- Investing Talvotech at Jefferies Conference: Strategic Growth in Biosimilars
- Investing Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech
- Investing Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda ® (pembrolizumab)
- Investing Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million
- Investing Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
- Investing Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
- Benzinga Why Is Teva Stock Trading Higher On Tuesday? - Teva Pharmaceutical Indus (NYSE:TEVA)
- Investing UBS sees limited cost pass-through for US generic drug firms
- Investing Alvotech at BofA Securities Healthcare Conference: Strategic Biosimilar Focus
- Benzinga Groupon Posts Upbeat Earnings, Joins Axon Enterprise, Warner Bros. Discovery, MercadoLibre And Other Big Stocks Moving Higher On Thursday - AppLovin (NASDAQ:APP), Alvotech (NASDAQ:ALVO)
日范围
9.14
9.73
年范围
7.35
13.70
- 前一天收盘价
- 9.72
- 开盘价
- 9.71
- 卖价
- 9.28
- 买价
- 9.58
- 最低价
- 9.14
- 最高价
- 9.73
- 交易量
- 885
- 日变化
- -4.43%
- 月变化
- 2.77%
- 6个月变化
- -25.04%
- 年变化
- -22.02%
31 七月, 星期四
11:30
USD
- 实际值
- 预测值
- 前值
- 47.999 K
11:30
USD
- 实际值
- 预测值
- -68.3%
- 前值
- -1.6%
12:30
USD
- 实际值
- 预测值
- 0.4%
- 前值
- 0.2%
12:30
USD
- 实际值
- 预测值
- 2.6%
- 前值
- 2.7%
12:30
USD
- 实际值
- 预测值
- 0.2%
- 前值
- 0.1%
12:30
USD
- 实际值
- 预测值
- 2.3%
- 前值
- 2.3%
12:30
USD
- 实际值
- 预测值
- 0.2%
- 前值
- -0.1%
12:30
USD
- 实际值
- 预测值
- 0.7%
- 前值
- -0.4%
12:30
USD
- 实际值
- 预测值
- 0.0%
- 前值
- -0.3%
12:30
USD
- 实际值
- 预测值
- 0.9%
- 前值
- 0.9%
12:30
USD
- 实际值
- 预测值
- 1.0%
- 前值
- 1.2%
12:30
USD
- 实际值
- 预测值
- 0.7%
- 前值
- 0.8%
12:30
USD
- 实际值
- 预测值
- 224 K
- 前值
- 217 K
12:30
USD
- 实际值
- 预测值
- 1.966 M
- 前值
- 1.955 M
12:30
USD
- 实际值
- 预测值
- 222.299 K
- 前值
- 224.500 K
13:45
USD
- 实际值
- 预测值
- 42.4
- 前值
- 40.4
14:00
USD
- 实际值
- 预测值
- 2.3%
- 前值
- 2.0%
14:30
USD
- 实际值
- 预测值
- 2 B
- 前值
- 23 B
15:30
USD
- 实际值
- 预测值
- 前值
- 4.245%
15:30
USD
- 实际值
- 预测值
- 前值
- 4.265%